Cargando…
Fixed-Dose Recombinant Urate Oxidase in the Treatment of Paediatric Tumour Lysis Syndrome: A Regional Cancer Centre Experience
BACKGROUND: Tumor lysis syndrome (TLS) is an oncologic emergency commonly seen in children with hemato-lymphoid malignancies. Recombinant urate oxidase (RUO) is used in both the prophylaxis and treatment of TLS. However, in resource-constrained countries, its role is mostly limited to the treatment...
Autores principales: | L, Appaji, Reddy, Jyothi. M, Chebbi, Pooja Gujjal, Kumar, Nuthan, AR, Arun Kumar, M, Padma, B S, Aruna Kumari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080352/ https://www.ncbi.nlm.nih.gov/pubmed/34967569 http://dx.doi.org/10.31557/APJCP.2021.22.12.3897 |
Ejemplares similares
-
Tuberculosis Coexistence in Pediatric Hodgkin’s Lymphoma: A Tropical Country Experience
por: Padma, Maneya, et al.
Publicado: (2020) -
Epidemiology and clinical features of retinoblastoma: A tertiary care center's experience in India
por: Padma, Maneya, et al.
Publicado: (2020) -
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
por: Pession, Andrea, et al.
Publicado: (2008) -
Flagellate erythema induced by bleomycin toxicity
por: Appaji, L., et al.
Publicado: (2013) -
An Optical Urate Biosensor Based on Urate Oxidase and Long-Lifetime Metalloporphyrins
por: Falohun, Tokunbo, et al.
Publicado: (2020)